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Abstract
Kaposi’s sarcoma (KS) lesions are complex mixtures of KS-associated herpesvirus (KSHV)-infected spindle and inflammatory
cells. In order to survive the host immune responses, KSHV encodes a number of immunomodulatory proteins, including the
E3 ubiquitin ligase K5. In exploring the role of this viral protein in monocytes, we made the surprising discovery that in
addition to a potential role in down regulation of immune responses, K5 also contributes to increased proliferation and
alters cellular metabolism. This ubiquitin ligase increases aerobic glycolysis and lactate production through modulation of
cellular growth factor-binding receptor tyrosine kinase endocytosis, increasing the sensitivity of cells to autocrine and
paracrine factors. This leads to an altered pattern of cellular phosphorylation, increases in Akt activation and a longer
duration of Erk1/2 phosphorylation. Overall, we believe this to be the first report of a virally-encoded ubiquitin ligase
potentially contributing to oncogenesis through alterations in growth factor signaling cascades and opens a new avenue of
research in K5 biology.
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Introduction
Tumor progression is a convoluted process that involves changes
in tumor-initiating cells and the surrounding stroma. Increases in
glucose uptake and lactate production are salient features of about
90% of all cancer cells and are routinely used in the clinical setting
to identify tumor cells using PET and HMR spectroscopy [1,2].
Stromal cells, thought to be important in the maintenance and
metastasis of tumors, also exhibit similar changes in metabolic
profiles driven by factors released from the transformed cells [1,3].
Understanding and dissecting the role of stromal cells in metastatic
progression is made difficult by the fact that changes in these cells
are not due to genetic lesions, but are a product of the surrounding
microenvironment. Historically, tumor viruses have proven to be
valuable tools for dissecting the molecular mechanisms of
transformation since these pathogens, by definition, encode at least
the minimal requirements needed for tumorigenesis in their host. It
is clear from almost two decades of research that products encoded
by Kaposi’s sarcoma-associated herpesvirus (KSHV) are essential in
driving at least three different neoplasias, Kaposi’s sarcoma (KS),
primary effusion lymphoma (PEL) and plasmablastic multicentric
Castleman’s disease (MCD) [4-6]. Our understanding, however, of
the mechanism of KSHV-driven tumor progression is still limited
and requires further examination.
KS lesions are histologically complex, comprised of KSHV-
infected endothelial cells, but also infiltrating inflammatory cells.
The role of these cells in the pathology of the disease or in the viral
life cycle is somewhat unclear. As with a variety of tumors resulting
from genetic lesions, monocytes and monocyte-derived cells within
KS lesions could play a critical role in tumor progression, releasing
a variety of cytokines that promote expansion of the surrounding
latently infected cells, while suppressing or skewing the anti-tumor
immune response [7-9]. Indeed, KSHV-driven neoplasias are
known to be dependent on a variety of both virally- and host-
encoded cytokines and growth factors [10-13]. A variety of
publications have described alterations in monocyte-lineage cell
function following either KSHV infection or in response to virally
encoded products. For example, the viral OX2 homologue has
been shown to alter cytokine release from macrophages both in cis
and in trans, increasing IL-1ß, IL-6 and TNF-a, also suppressing
IFN-c stimulated immune responses [14,15]. Similar up regulation
of IL-6 and IL-10 expression was seen following expression of two
KSHV-encoded microRNAs in monocytes [16]. Infection of the
THP-1 human monocyte cell line has been shown to alter TLR3
expression and function, mediating increased release of CXCL10
and IFN-b1 [17]. These lines of data open the door for direct
infection of monocytes playing a role in tumor progression, further
supported by the ability of KSHV to utilize DC-SIGN, a molecule
expressed on monocyte-derived cells and activated B cells, as a co-
receptor to increase infectivity [18-20].
A number of both lytic and latent KSHV encoded gene
products are believed to play a role in KS pathogenesis. The
KSHV latency-associated proteins are readily detectable in KS
tumors, however, none of these products has been shown to be
sufficient for inducing sarcomagenesis in mouse models [21,22].
On the other hand, lytic gene products can transform endothelial
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vGPCR to be a major oncogene [21,23]. However, only a subset
of cells within KS tumors, not the predominant spindle-shaped
endothelial cells, display a lytic pattern of gene expression
confounding the contribution of KSHV lytic genes in KS
pathogenesis [24,25]. By definition, cells expressing the lytic gene
program are fated to die, giving rise to hypothesis that a low
proportion of lytically-infected cells in the tumor are providing
paracrine factors to promote tumorigenesis.
The K5 protein of KSHV (also termed modulator of immune
responses 2 (MIR 2)) is the prototypical member of the membrane-
associated, RING-CH containing (MARCH) E3 ubiquitin ligase
family. Work from our lab and from manyothers have shown that this
protein is able to target a variety of immunomodulatory proteins for
down regulation, presumably leading to reduced immune responses
against virally-infected cells (reviewed in [26]). While K5 has been
characterized as a lytic protein, its expression is also driven by cellular
Notch signaling, potentially allowing for expression independent of
the full lytic cycle [27,28]. A more recent report looking at the
epigenetic status of the KSHV genome has reported a large number
of activating histone modifications and a paucity of inhibitory marks
in the K5 gene loci in latently infected cells, raising questions about its
definition as a lytic gene product [29]. Finally, immuno-histochemical
studies have shown that K5 is expressed in KS tumors, as well as in
PEL and MCD together raising the intriguing possibility of a role for
K5 in KSHV mediated oncogenesis [30].
Given a potential role for monocyte-derived cells in the
pathogenesis of KSHV-driven neoplasias and the ability of the
KSHV K5 protein to regulate the anti-viral immune responses, we
undertook a study of the ability of this immune evasion molecule
to alter monocyte functionality. To our surprise, we observed that
in addition to potentially altering anti-viral immune responses, the
K5 protein is able to alter monocyte metabolism and replication
rate. K5-mediated alterations potentially contribute to tumorigen-
esis by altering the surrounding microenvironment through
induction of aerobic glycolysis with release of lactate and
increasing sensitivity of tumor cells to paracrine factors. Mecha-
nistically, this occurs through targeting and re-localization of a
subset of growth factor-binding receptor tyrosine kinases, enhanc-
ing pro-proliferation and survival signaling. We believe that this
report represents the first example of a virally-encoded E3
ubiquitin ligase acting as a transforming factor.
Results
KSHV K5 alters monocyte proliferation
To investigate a potential role for K5 in altering monocyte
functionality, the human monocyte cell line THP-1 was transduced
to stablyexpress empty vector or WT (wild-type) K5. Unexpectedly,
following antibiotic selection, cells expressing WT K5 had a
markedly decreased doubling time (,15 hours vs. ,28 hours) and
achieved higher culture densities than vector-expressing THP-1
cells. To ensure this was not an artifact of selection, retroviral
transduction of cells was repeated, using additional viruses encoding
mutants of K5 that alter the ability of the protein to down regulate
immunomodulatory proteins [31]. Once again, cells expressing WT
K5 had a significantly increased rate of growth as compared with
vector-transduced cells (Fig. 1A). Additionally, this ability to
increase cellular replication rate was maintained by K5 expression
constructs containing a mutation of the proline-rich, potential SH3-
binding domain (K5 P/A) or the downstream acidic residues (K5
DE12) (Fig. 1A and data not shown). However, three other
constructs, K5 Y/A, containing a mutation in the tyrosine-based
endocytosis motif and two constructs lacking E3 ubiquitin ligase
activity, mZn and W47A, did not significantly alter the growth rate
of THP-1 monocytes (Fig. 1A and data not shown).
As a first exploration of the mechanisms underlying this
increased proliferation, vector expressing- and WT K5-expressing
THP-1 cells were tested for serum dependency. At low serum
concentrations (0.5% FBS), there was minimal change in the
growth rate of vector cells as compared with growth in 10% FBS,
while there was a dramatic reduction in proliferation of the WT
K5-expressing cells (Fig. 1B). Examination of the cell cycle profile
of these cells revealed that in the presence of high serum
concentrations approximately 15% more WT K5 cells were in
S-phase, with a significant decrease in cells in G0/G1, as
compared to vector-expressing cells (Fig. 1C). This same increase
in S-phase cells was seen for the K5 P/A-expressing cells, while the
cell cycle profile of those expressing the K5 Y/A mutant
resembled the THP-1 vector cells. Switching the WT K5 or K5
P/A cells to low serum resulted in a decrease in S-phase cells, with
concomitant increase in cells in G0/G1, such that they resembled
vector-expressing cells. Co-staining of cells with Annexin V and
propidium iodide revealed that less than 5% of vector-THP-1 or
K5 Y/A-expressing cells stained positive for apoptosis in the
different serum concentrations. However, in WT K5 and K5 P/A
cells, the percentage of cells undergoing apoptosis increased from
,10% in high serum conditions to greater than 20% of cells under
low serum conditions (Fig. 1D). Intriguingly, in medium
containing 10% charcoal-stripped FBS, WT K5 cells still
maintained a high proliferation rate, while vector-THP-1 cells
exhibited a significantly decreased proliferation rate (Fig. S1A).
Together, this data suggests that K5 might be acting to increase
monocyte responsiveness to serum-derived growth factors.
K5 expressing THP-1 cells have altered metabolism
During growth rate analysis, we also noticed that any of the
THP-1 lines expressing a K5 construct which decreased doubling
time also acidified the growth medium at a more rapid rate,
independent of cell number, as compared to vector-expressing
THP-1 cells. Over a one day period the medium containing
vector-THP-1 or K5 Y/A expressing THP-1 cells decreased in pH
from 7.8 to 7.0, while the medium from K5 WT or K5 P/A-
expressing cells dropped to 6.5. This drop in pH was visible as a
change in indicator color in the medium which could also be
measured as a drop in optical density at 570 n.m. (Fig. 2A). This
led us to question whether this rapid change in culture pH due to a
Author Summary
Tumor viruses have proven to be valuable tools for
dissecting the molecular mechanisms of transformation
and cancer progression. Kaposi’s sarcoma-associated
herpesvirus (KSHV) infection is essential in driving at least
three different neoplasias, including Kaposi’s sarcoma (KS).
Our understanding, however, of the molecular mechanism
of KSHV-driven tumor progression is still limited and
requires further examination. In this manuscript we
demonstrate that the K5 E3 ubiquitin ligase of KSHV is
able to alter monocyte metabolism, driving increased
glucose consumption and lactate production, hallmarks of
virtually every cancer. It is able to accomplish this through
a modulation of selected receptor tyrosine kinases, whose
normal role is to bind pro-growth factors. Indeed, this
alteration in metabolism is coupled with increases in
monocyte proliferation. Our study provides insights into
the mechanisms of KSHV-driven oncogenesis, as well as a
new tool for exploring the link between metabolism and
cancer.
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that occurs in a virtual plurality of tumors and is dubbed the
O ` Warburg EffectO ´ (reviewed in [32]). Equal numbers of WT K5-,
K5 Y/A-, K5 P/A and vector-expressing THP-1 cells were
incubated with the fluorescent glucose analog 2-NBDG and
uptake was measured over a period of thirty minutes. There was a
greater than four fold increase in the uptake of glucose in K5-WT
and K5 P/A-expressing THP-1 cells when compared to the
parental cells (Fig. 2B). Lactate secretion into the media was
followed over a longer, 24-hour period. Equal numbers of vector-,
K5 WT-, K5 Y/A and K5 P/A-expressing THP-1 cells were
seeded into culture vessels, samples were taken at various time
points, cells enumerated and supernatant was subjected to
colorimetric measurement of lactate concentration. After normal-
Figure 1. THP-1 cells stably expressing wild-type K5 have increased growth rate, which is serum dependent. THP-1 cell lines were
seeded at 0.1 x 10
6 cells/ml in RPMI media supplemented with (A) 10% FBS or (B) 5% and 0.5% FBS, as indicated, in triplicates. Viable cell numbers
and averages were determined for each day. (C) Equal numbers of indicated THP-1 cell line in medium with either 10% FBS (top panel) or 0.5% FBS
(bottom panel), were examined for cell cycle profile, as described in the Methods, at three days post-seeding. Results are representative of three
independent experiments. (D) Each of the indicated THP-1 cells was seeded in triplicate at 0.1 x 10
6 cells/ml in medium containing the indicated
serum concentration. Five days post-seeding cells were examined for apoptosis. The percentage of cells doubly stained for Annexin V and propidium
iodide are indicated.
doi:10.1371/journal.ppat.1001331.g001
Viral E3 Ligase Induction of the Warburg Effect
PLoS Pathogens | www.plospathogens.org 3 April 2011 | Volume 7 | Issue 4 | e1001331Figure 2. THP-1 and TIME cells stably expressing wild-type K5 have an altered metabolism. (A) Medium from equal numbers of the
indicated cells were examined at 3 days post-seeding both visually (left panel) and for absorbance at 570 nm (O.D.570) (right panel) (B) Equal numbers
of each THP-1 cell line were starved for 3 hours and incubated in glucose free DMEM medium with a fluorescent glucose analog (2-NBDG) (0.1 mM)
for a period of 30 minutes. Live cells were gated and the fluorescence intensity assessed by flow cytometry at the indicated time points. A
representative experiment of analog uptake (left panel) and the quantification of fold change after 30 min. with standard deviations (right panel) are
shown. (C) Cells were seeded in triplicate at 0.1 x 10
6 cells/ml and supernatant was taken at the indicated time points and subjected to colorimetric
measurement of lactate concentration. (D) Cells were seeded at 0.1 x 10
6 cells/ml in glucose-free DMEM media supplemented with different
Viral E3 Ligase Induction of the Warburg Effect
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hour period for K5-expressing THP-1 cells was 3.80 mmoles/
hour/1*10
5 cells, almost ten fold more than in vector-expressing
THP-1 at 0.41 mmoles/hour/1*10
5 cells (Fig. 2C). The K5 P/A-
and K5 Y/A-expressing cells behaved similarly to K5 WT- and
vector-expressing THP-1 cells, respectively.
To determine if this ability of the K5 protein to alter cellular
metabolism and increase lactate production was limited to
monocytes, we established K5-expressing telomerase-immortal-
ized microvascular endothelial cells (TIME). TIME cells have
been previously used by a number of groups to model KSHV
infection of endothelial cells in the KS tumors [33,34]. As in the
THP-1 cells, K5-expression was very low and observed only
following protein immunoprecipitation however, we were able to
demonstrate down regulation of MHC I, indicating that K5 is
functional in TIME cells (data not shown). We did not observe a
decrease in doubling time, but we did observe an approximately
2.3 fold increased lactate production in medium containing high
concentrations of growth factors, as compared with TIME cells
transduced with vector alone (data not shown). This increase in
lactate production was amplified when cells were switched to
DMEM supplemented with 10% serum only with TIME K5 WT
cells producing almost 5 fold more. Finally, we also examined
lactate production in KSHV-infected TIME cells. The published
literature indicates that at short-time points following infection
there are increases in lactate production [35]. We did not
observe such an increase at the longer time post-infection
(greater than 3 weeks) points examined in our studies (data not
shown).
Another feature of many cancer cells that have shifted their
metabolism to aerobic glycolysis is an increased dependence on
glucose for growth and an up regulation of glucose transporters
[36]. To test if WT K5-expressing THP-1 cells are addicted to
glucose for their growth, equal numbers of cells were seeded in
complete medium with different concentrations of glucose (0-
12mM). While vector-expressing THP-1 failed to proliferate in
glucose-free media, their growth rate was essentially unchanged
under low versus high glucose concentrations (Fig. 2D). In
contrast, the proliferation rate of the K5-expressing cells was
directly proportional to the concentration of glucose in the media.
We observed similar results when varying the glutamine
concentration (Fig. S1B). RT-PCR array was used to examine
levels of glucose transporter message in K5- versus vector-
expressing cells. Overall levels of GLUT4 (SLC2A4) message
increased almost 700 fold, while more modest increases in both
GLUT1 (SLC2A1) and GLUT3 (SLC2A3) were observed (Table
S1).
As a final measurement of metabolic shift induced by K5
expression, we measured the relative amounts of phosphorylated
pyruvate kinase M2 isozyme. Phosphorylation of the M2 form
decreases the ability of the enzyme to form homo-tetramers,
negatively impacting its ability to convert phosphoenolpyruvate to
pyruvate, promoting aerobic glycolysis [37,38]. Western blot (WB)
analysis with a phospho-specific PKM2 antibody revealed a
dramatic increase in reactive protein in both K5 WT- and K5 P/
A-expressing THP-1, as compared to either vector- or K5 Y/A-
expressing cells (Fig. 2E). An increase in the phosphorylated
PKM2 was also seen in TIME K5 cells as compared to TIME cells
expressing vector only (Fig. 2E).
K5 induces changes in HIF-1a and Akt activation
One of the fundamental contributors to the Warburg Effect has
been suggested to be the HIF-1a protein, the master regulator of
oxygen homeostasis in cells [39,40]. Although induced by hypoxia
in the low oxygen tension tumor microenvironment, it can also be
stabilized under normoxic conditions by multiple pathways
involving increased glycolysis and lactate production, Akt pathway
activation, or loss of the PTEN tumor suppressor [41-44]. WB
analysis of normalized whole cell lysates (WCL) from THP-1 lines
cells grown under normoxic conditions demonstrated readily
detectable HIF-1a protein in both WT K5- and K5 P/A-
expressing THP-1 cells, while HIF-1a protein was almost
undetectable in vector- and K5 Y/A expressing cells (Fig. 3A).
There is evidence in the literature that the HIF-1a protein can
negatively regulate mitochondrial biogenesis, contributing to the
decreased respiration under aerobic conditions seen for many
tumor lines [45]. Equal numbers of vector-, WT K5-, K5 Y/A-
and K5 P/A-expressing THP-1 cells were subject to flow
cytometry analysis using the fluorescent stains, Mitotracker Green
(mass) and Mitotracker Red (membrane potential). In contrast to
the expected result, quantification of the relative levels of staining
in each cell line indicates that mitochondrial mass was preserved,
but membrane potential in the WT K5- and K5 P/A-expressing
THP-1, which also demonstrated increased HIF-1a protein levels,
were two fold lower as compared to vector- and K5 Y/A-
expressing cells (Fig. 3B). Interestingly, WT K5-expressing THP-1
maintains an equal or slightly increased oxygen consumption rate
as compared to vector-expressing THP-1 (data not shown).
HIF-1a protein stabilization has also been implicated in
activating Akt under normoxic conditions [46,47]. Furthermore,
Akt is not only the most activated serine/threonine kinase in myriad
of cancers, but it has also been shown to be an important inducer of
the Warburg effect by stimulating aerobic glucose metabolism
through increased expression of GLUT receptors [36,48,49].
Normalized WCL from the THP-1 lines were subjected to WB,
probing with p-Akt (Ser 473) and p-Akt (Thr 308) antibodies. There
was comparatively increased phosphorylation of Akt at both sites in
WT K5- and K5 P/A-expressing THP-1 cells, while total Akt levels
were essentially equal in all cells (Fig. 3C).
K5-expressing THP-1 have altered total phosphorylation
levels
Akt is activated in a phosphoinositide 3-kinase (PI3K)-
dependent manner that is downstream of growth factor receptor
tyrosine kinases (RTKs) [50]. Since WT K5-expressing THP-1
cells show robust activation of Akt and serum dependency, we
decided to explore the activation of RTKs and their contribution
to subsequent downstream signaling through the PI3K/Akt
pathway.
To check the activation of RTKs and proximal signaling, we
first examined total tyrosine phosphorylation. Normalized WCL of
vector- and WT K5-THP-1 cells, mock or pervanadate (PV)
treated for ten minutes, were subject to WB with a p-Tyr antibody.
In these experiments, the WT K5-THP-1 cells contained
increased amounts of total p-Tyr reactive proteins, as compared
with vector-expressing THP-1 cells, but the pattern of phosphor-
ylation between the two cell lines looked largely similar (Fig. 4A,
left panel). The amount and pattern of phosphorylation of the K5
concentrations of glucose (12 mM, 6 mM, 2 mM or 0 mM). Viable cell numbers were determined daily. Data are representative of three experiments.
(E) Normalized whole cell lysate of each of the indicated THP-1 and TIME cell lines were subject to western blot (WB) using an anti-phospho-PKM2
(Tyr 105) antibody and re-probed with anti-PME-1 antibodies.
doi:10.1371/journal.ppat.1001331.g002
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and WT K5-THP-1 cells, respectively (Fig. 4A, right panel).
Normalized WCL of the THP-1 lines were next subjected to
WB with either p-Thr or p-Ser antibodies. Both the WT K5- and
K5 P/A-expressing THP-1 cells had alterations in serine and
threonine phosphorylation, as compared with vector- or K5 P/A-
expressing THP-1, indicating downstream signaling activity is also
altered (Fig. 4B and C).
K5-expressing THP-1 activate a specific cluster of RTKs
Since there were clear increases in tyrosine phosphorylation and
altered overall phosphorylation in WT K5-expressing THP-1 cells,
we next examined whether RTKs are differentially activated in
vector- and K5-expressing THP-1. Following overnight serum
starvation and treatment for 10 min with 10% FBS, normalized
WCL of vector- or WT K5-expressing THP-1 cells were incubated
with an array spotted with antibodies against 42 different RTKs.
Activation of captured RTKs was then interrogated using a p-Tyr
antibody. Multiple independent experiments demonstrated vari-
able, but increased activation of Axl, Flt-3, Flt-4 and PDGFR-ß in
WT K5-expressing THP-1 cells, as compared with vector-
expressing cells. Interestingly, vector-THP-1 cells demonstrated
activation of both the MCSF-R and Insulin-R that was not seen in
the K5-expressing cells (Fig. S2).
RTK inhibitors reduce growth rate of K5-expressing THP-1
As a first verification of the array data, cells were serum starved
overnight and then treated with a relatively plieotropic RTK
inhibitor, sunitinib (2mM), or DMSO, followed by stimulation
with 10% FBS for ten minutes. Equal amounts of WCL were
subjected to WB with a p-Tyr antibody. While there was only low
level phosphorylation in vector-expressing THP-1 cells, either or
without sunitinib treatment, WT K5-THP-1 cells demonstrated
robust phosphorylation that was largely abrogated by sunitinib
Figure 3. K5 expressing cells have other features of the Warburg Effect. (A) Normalized whole cell lysate of each of the indicated THP-1 cell
lines were subject to western blot (WB) using an anti-HIF-1a antibody (top panel) and re-probed with anti-ß-actin antibodies (bottom panel).
(B) Equal numbers of the indicated cell lines were stained with mitotracker green (Mitochondrial Mass) or mitotracker red (Membrane Potential) and
subjected to flow cytometric analysis. (C) Normalized whole cell lysates were subjected to western blot (WB) using anti-phospho-Akt (Ser473) (top
panel), anti-phospho-Akt (Thr308) (middle panel) or total Akt (bottom panel) antibodies. Data for all panels are representative of three independent
experiments.
doi:10.1371/journal.ppat.1001331.g003
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produced less clear results. Incubation of vector- or K5-
expressing THP-1 with 2mM sunitinib in 2%FBS resulted in a
nearly equivalent average increase in doubling time, 1.33 fold
(28.8 hrs to 38.4 hrs) and 2.06 fold (21.3 hrs to 39.6 hrs),
respectively (data not shown). Interestingly, however, we also
observed that treatment with sunitinib blocked acidification of the
medium and reduced lactate production on a per cell basis (data
not shown).
As an additional validation of the RTK array data, identified
receptors were examined individually in THP-1 cell lines. First,
normalized WCL of the THP-1 lines, treated with PV and 10%
FBS for ten minutes post overnight serum starvation, were
subjected to immunoprecipitation (IP) using a Flt-3 antibody
Figure 4. K5 alters tyrosine, serine and threonine phosphorylation. (A, left panel) Vector- and K5 WT-expressing THP-1 cells were mock (-)
or pervanadate (PV) treated for ten minutes and normalized whole cell lysates were subjected to western blot (WB) using an anti-phospho-tyrosine
(4G10) (pTyr) antibody. Normalized whole cell lysates from PV treated THP-1 cell lines, as indicated, were subjected to western blot using (A, right
panel) anti-phospho-tyrosine (4G10) (pTyr), (B) anti-phospho-serine (pSer) or (C) anti-phospho-threonine (pThr) antibodies. Data for all panels are
representative of three independent experiments.
doi:10.1371/journal.ppat.1001331.g004
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tyrosine phosphorylation of Flt-3 in WT K5- compared to vector-
expressing THP-1 cells, while total Flt-3 levels remained the same
(Fig. 5B). Similar results were seen for PDGFR-ß and Axl (data not
shown). Due to experimental limitations, the activation of Flt-4
was examined in HEK-293T cells by transiently expressing K5
and either Flt-4 or a Flt-4 protein containing a mutation in the
kinase domain, which renders it inactive. Following transfection,
Figure 5. THP-1 cells stably expressing K5 WT have sunitinib-sensitive increased RTK phosphorylation. (A) Normalized whole cell
lysates from THP-1 cells, mock (PBS) or sunitinib (2 mM) treated, were subjected to western blot using an anti-phospho-tyrosine (4G10) (pTyr)
antibody (top panel) and reprobed with an anti-actin antibody (bottom panel) to demonstrate equal loading. (B) Normalized WCL from parental or K5
WT-expressing THP-1 cells were subject to immunoprecipitation (IP) using anti-Flt-3 antibodies followed by western blot (WB) using an anti-phospho-
tyrosine (4G10) (pTyr) antibody (top panel). The IP (middle panel)and whole cell lysates (WCL) (bottom panel) were probed with anti-Flt-3 antibodies,
as controls. (C) 293T cells were co-transfected with expression constructs for K5 and Flt-4 or a Flt-4 mutant (G857R). Two days post-transfection, cell
lysates were subjected to IP using anti-Flt-4 antibodies. western blot (WB) was performed using anti-phospho-tyrosine (4G10) (pTyr) antibodies (top
panel) and re-probed with anti-Flt-4 antibodies (bottom panel). Data for all panels are representative of three independent experiments.
doi:10.1371/journal.ppat.1001331.g005
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with a p-Tyr antibody. The phosphorylation of Flt-4 was increased
the presence of K5, as compared to vector (Fig. 5C). As expected,
this phosphorylation was not seen for Flt-4 containing a mutation
in the kinase domain.
K5-expressing THP-1 cells are more responsive to Flt-3L
and PDGF-ß
Given the increased phosphorylation of several RTKs in K5-
expressing THP-1, combined with the increased doubling time in
the presence of low serum concentrations, we next explored
whether K5 was acting not to directly activate these receptors, but
to modulate their responses to ligands. Equal numbers of cells
from each of the THP-1 lines were serum starved overnight and
then were Flt-3 ligand or mock treated for ten minutes followed by
washing and incubation at 37uC for various times, as indicated.
Normalized WCL from PV treated cells were subjected to WB
with a p-Tyr antibody. As shown in Figure 6A, WT K5-expressing
THP-1 cells are comparatively more responsive to Flt-3 ligand,
with the most robust signaling activity seen around 3 hours post
stimulation, while there was a minimal, but detectable response in
vector-expressing cells. Similar results were obtained when the
experiment was repeated with PDGF-ß (Fig. 6B).
To determine whether activation of the RTKs by specific
ligands induced downstream MAPK signaling, we focused on the
activation of Erk in the THP-1 cell lines. A similar time course
experiment was set up as for the Flt-3 activation experiment, but
the WCL were probed with p-Erk1/2 and Erk2 antibodies after
blotting. Erk1/2 demonstrated a higher basal and a longer
duration of activation in WT K5-expressing THP-1 cells, as
compared to vector-THP-1 cells (Fig. 6C). Similar results were
obtained following PDGF-ß stimulation (data not shown).
K5-expressing THP-1 cells have lower surface, but
increased intracellular RTK levels
Since there is increased signaling through selected RTKs in WT
K5-expressing THP-1 cells, we first hypothesized that K5
prevented RTKs from being internalized and degraded, thus
allowing for a longer duration of signaling from the cell surface.
Contrary to our hypothesis, examination of the THP-1 lines by
flow cytometry revealed that while vector- and K5 Y/A-expressing
THP-1 lines had a high surface expression of all three RTKs, WT
K5- and K5-P/A-expressing lines had minimal expression
(Fig. 7A). As expected, both the K5 W47A- and K5 mZn-
expressing THP-1 showed surface levels of all three RTK
comparable to vector-expressing cells (data not shown). Examina-
tion of the EGFR, which was present in our phospho-RTK array
analysis but did not show differential activation in the K5-
expressing cells, demonstrated no difference in cell surface
expression for any of the lines. We next examined whether there
were increases in intracellular RTK expression. Flow cytometric
analysis of permeabilized cells revealed that while the relative ratio
of total to surface RTK amounts in vector- and K5 Y/A THP-1
cell lines was approximately 1, this ratio was considerably greater
in both the WT K5- and K5 P/A-expressing THP-1 cell lines
(Fig. 7B and inset). Again, no effect of K5 WT or K5 P/A was
observed on EGFR with regards to total protein or the ratio of
surface to intracellular protein.
K5 forms complexes with the activated RTKs
Given the increased amounts of internalized RTKs in WT K5-
expressing THP-1 cells, we next examined whether K5 was able to
form complexes with the identified RTKs. HEK-293T cells were
co-transfected with either GST-fusion constructs of K5 along with
EGFR (negative control), PDGFR-ß, or Flt-4 constructs. After
pulldown with glutathione beads, WB was performed on
precipitated proteins and WCL using EGFR, Flt-4 and PDGFR-
ß antibodies. Neither the WT K5 or K5 mutant constructs were
able to interact with EGFR, although expression levels were
equivalent (Fig. 7C). All of the GST-tagged K5 constructs were
able to interact with both PDGFR-ß and Flt-4, while no binding
was seen with the empty vector expressing only the GST-AU1
fusion construct. Interestingly, K5 Y/A, which has been shown to
be deficient in mediating endocytosis of other K5 targets, can still
interact with the RTKs suggesting that simple interaction with the
RTKs is not sufficient for increased signaling [31]. Additionally,
Figure 6. K5 WT-THP-1 cells are more responsive to Flt-3 and
PDGF-ß-induced signaling and have increased Erk activation.
Equal numbers of vector- and K5 WT-expressing THP-1 cells were serum
starved overnight and stimulated with (A and C) Flt-3L (40 ng/ml) or
(B) PDGF-ß (20 ng/ml) for ten minutes after which cells were washed
and then treated with pervanadate for ten minutes at the times
indicated. Western blot (WB) was performed on normalized whole cell
lysates using (A and B) anti-phospho-tyrosine (4G10) (pTyr) or (C) anti-
phospho-Erk antibodies. For panels A and B, 10 ug of THP-1 K5 WT
lysate and 30 ug of THP-1 lysate were loaded to make comparison of
bands easier between the two cell lines. Equal amounts of each lysate,
30 ug/lane, were loaded for panel C. Blots were re-probed for actinin
(A and B) or total Erk (C). Data are representative of three independent
experiments.
doi:10.1371/journal.ppat.1001331.g006
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the K5 W47A construct. This mutant of K5 lacks E3 ubiquitin
ligase activity, indicating this function is not necessary for the
interaction (data not shown).
The endocytosis of RTKs is necessary for increased
signaling in presence of K5
To further determine if K5 mediates endocytosis of RTKs from
the surface, we did a time course study in the THP-1 lines with
dynasore, a reversible inhibitor of dynamin [51,52]. Following
treatment for one hour, drug was washed out and cells were placed
at 37uC for various amounts of time, after which cells were stained
and analyzed by flow cytometry. While the surface expression of
RTKs in vector-THP-1 cells changed minimally pre- and post-
dynasore treatment, the surface expression of Flt-3, Flt-4 and
PDGFR-ß in K5-THP-1 cells went up 5 fold, 5.5 fold and 8 fold,
respectively (Fig. 8A). These increases were mirrored in the K5 P/
A-expressing cells, while the K5 Y/A-expressing cells resembled
vector-expressing THP-1. These surface levels in the K5 WT- and
K5 P/A-expressing cells decreased rapidly following drug removal
to the levels seen in mock treated cells.
Given that altered signaling pathway activation was seen only in
cells expressing K5 variants capable of inducing RTK endocytosis,
we next explored whether endocytosis was required for increased
signaling. Equal numbers of THP-1 cells were either mock or
dynasore treated for 60 min., followed by washing and re-
suspension in medium containing 10% FBS. Cells were collected
pre-dynasore treatment, after 1 hour of treatment and at two time
points post-washout. WCL from each time period were subjected
to WB with a p-Tyr antibody. K5-expressing THP-1 cells treated
with dynasore had markedly decreased tyrosine phosphorylation
when compared to mock (DMSO) treated cells, while there was
minimal change in vector-expressing THP-1 cells with or without
dynasore treatment (Fig. 8B). Following dynasore removal we
observed a rapid recovery of tyrosine phosphorylation in the K5-
expressing THP-1 cells. Interestingly, increased p-Tyr reactivity
was not seen to increase if cells were re-suspended in serum-free
medium following drug washout (data not shown).
Discussion
In this study, we show for the first time that a viral E3 ubiquitin
ligase, KSHV K5, can act as a pro-oncogenic factor altering
metabolism and increasing pro-growth, proliferation and survival
signaling cascades. K5-expressing monocyte cell lines display
increased dependency on glucose and glutamine, coupled with
higher rates of glucose uptake and lactate production (Figs. 2B, C
& D, Fig. S1B). TIME cells stably expressing K5 also display many
of these changes suggesting that this viral protein might be acting
to alter metabolism both in the spindle cells making up the bulk of
the tumor, in addition to the surrounding stroma and inflamma-
tory cells and we are actively investigating this possibility (Figs. 2D
& 4E). More importantly, the discovery of a tumor virus protein
capable of inducing the Warburg effect provides the basis for a
model system to look more deeply at the role of metabolic
dysfunction in cancer.
We have shown that K5 is able to extend the duration and
increase the sensitivity of receptor tyrosine kinase signaling (Fig. 6).
Given that signaling from these receptors is still ligand dependent
and enhanced proliferation of K5-expressing THP-1 cell lines is
serum dependent, we do not believe that K5 is inducing receptor
activation in the absence of these serum factors (Figs. 1B & 8B).
However, this modulation by K5 results in a longer time course of
activation of multiple signaling cascades at a lower concentration
of ligand, including Akt and MAPK, leading to subsequent
increases in aerobic glycolysis and proliferation. KSHV infection
of endothelial cells has been shown by others to increase HIF
protein levels and confer increased survival through activation of
the Akt/mTOR pathway signaling, but no mechanism of pathway
activation was demonstrated [53,54]. We are currently exploring
the role that K5 plays in this upregulation of HIF-1a during
infection using viruses deleted for K5.
The mechanisms by which K5 alters monocyte metabolism are
likely to be complex. EGFR amplification in cancer has been
implicated in stabilizing glucose transporters, independent of its
ability to increase activation of down stream signaling pathways
[55]. This ability to stabilize glucose transporters has not been
examined for other RTKs, however our data shows increases in
Figure 7. K5 interacts with and alters RTK localization. Equal cell
numbers of the indicated THP-1 lines were fixed with paraformaldehyde
(PFA) and (A) stained without permeabilization to determine surface
expression or (B) permeabilized with saponin prior to staining to
determine total expression of Flt-4, PDGFR-ß, Flt-3 and EGFR by flow
cytometry. Data are representative of three independent experiments.
(B, Inset) The relative ratio of surface versus total RTKs was determined
for vector- and K5 WT-expressing THP-1 cells. (C) 293T cells were co-
transfected with expression constructs for EGFR, PDGFR-ß, or Flt-4 and
the indicated GST expression constructs. After two days, lysates were
subjected to GST pull-down using glutathione-sepharose beads.
Purified proteins and whole cell lysates (WCL) were subjected to
western blot (WB) using anti-EGFR, -Flt-4 or -PDGFR-ß antibodies,
followed by re-probing with anti-GST antibodies. Arrows indicate GST or
GST-K5 WT and mutant specific bands. Data are representative of three
independent experiments.
doi:10.1371/journal.ppat.1001331.g007
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PLoS Pathogens | www.plospathogens.org 10 April 2011 | Volume 7 | Issue 4 | e1001331Figure 8. K5 mediates rapid internalization of RTKs from the surface leading to increased signaling. (A) Equal numbers of the indicated
THP-1 lines were mock or Dynasore (80 mM) treated for an hour at 37uC. Cells were then released at 37uC in serum free media for 0, 5, 10 or 30
minutes. At the indicated time points, cell aliquots were fixed and stained for surface levels of Flt-3, Flt-4 and PDGFR-ß followed by flow cytometric
analysis. Representative experiments for each of the three receptors demonstrating the relative change in the expression of each RTK normalized to
the fluorescence (geometric means) of mock treated samples is shown as line graphs, while the overall endocytosis rate of the receptor tyrosine
kinases over the 30 minutes following dynasore release normalized to the time 0 point is shown as a bar graph with standard deviations. Line graph
results are representative of at least three experiments (B) Equal numbers of vector- and K5 wt-expressing THP-1 were seeded in media containing
2% FBS. Following treatment with DMSO (mock) or Dynasore (80 mM) for 60 min and release in Dynasore-free medium at 37uC for 0, 30 or 60 minutes
normalized whole cell lysates were prepared and subjected to western blot (WB) with an anti-phospho-tyrosine (4G10) (pTyr) antibody.
doi:10.1371/journal.ppat.1001331.g008
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decrease in lactate production in K5-expressing THP-1 cells
treated with sunitinib, suggesting that increased RTK signaling
and not transporter stabilization is responsible for the alterations in
metabolism (data not shown). We also observed that alongside
their increased dependence on glucose, K5-expressing cells also
displayed an increased dependence on glutamine with decreases in
mitochondrial potential (Fig. 3B & Fig. S1B). Interestingly, other
inhibitors including AG1295 (PDGFR-ß inhibitor, 50mM), Rap-
amycin (mTor inhibitor, 100nM) and Triciribine (AKT inhibitor,
1mM) also blocked medium acidification, while MEK and JNK
inhibitors did not, demonstrating the utility of this system for
examining Warburg induction and the linkage between glutami-
nolysis and mitochondrial biogenesis.
We have shown that changes in tyrosine phosphorylation
correspond with the growth and metabolism phenotype. The
vector- and Y/A- expressing cells, which do not display markers of
the Warburg effect, have decreased tyrosine phosphorylation
compared with wild-type K5- and P/A-expressing cells, suggesting
that increased signaling is probably coupled with altered
metabolism (Figs. 1, 2 & 4). This linkage has been observed
previously in the case of fibroblast growth factor receptor, with
constitutive signaling causing both increased phosphorylation and
partial inhibition of pyruvate kinase M2, leading to decreased
respiration [37]. The KSHV literature suggests that KS spindle
cells, which form the bulk of the tumor, are more dependent on
signals from growth factor signaling pathways, but do not contain
activating mutations. This has lent support to the rationale of using
sunitinib, a pleiotropic RTK inhibitor targeting a variety of RTKs
including Flt-3, PDGFR-a/ß and VEGFRs, for the treatment of
KSHV induced pathogenesis [56,57]. Intriguingly, sunitinib
inhibits K5-mediated activation of RTKs and decreases lactate
production (Fig. 5A and data not shown). Additionally, K5
alteration of metabolism and proliferation is also sensitive to
Rapamycin, another drug that is showing promise against KS in
the clinic [58-61] (Fig. S3). The data presented in this manuscript
open the possibility that these drugs, in addition to targeting
signaling pathways in the infected spindle cells, might also be
reducing the ability of infected cells to aid in tumor progression
through the release of lactate.
The fact that endocytosis of the RTKs, not just interaction with
K5, is required for the increased signaling, as evidenced by the
ability of dynasore to block increased tyrosine phosphorylation and
the interaction of K5 Y/A with the RTKs in pulldown assays, is a
very interesting finding (Figs. 7C and 8B). There are a large number
of mechanisms by which RTK signaling, without mutation of the
RTK, can be dysregulated in cancer. Our model shows a
requirement for an intact internalization machinery and argues
that very subtle mutations in trafficking proteins, that do not
increase cell surface receptor levels and in fact decrease surface
levels, could lead to unregulated receptor signaling. In keeping with
this model, it is thought that the full biological activity of RTKs is
conferred only after endocytosis, activating signal transducers like
Erk1/2 for robust and sustained signaling [62]. We have observed
and are currently exploring whether K5 interaction with two
different cellular proteins, CD2AP, a Cbl interacting protein and
filamin, a component of the cytoskeletal machinery, could be
important in this dysregulation (data not shown).
We have been unable thus far to observe increased ubiquityla-
tion of any of the explored RTKs in THP-1 cells in the presence of
K5. However, we did observe that while the K5 W47A mutant is
able to interact with the RTKs in transient assays (Fig. 7C), it did
not induce either increased endocytosis or changes in THP-1
proliferation (data not shown). Equally, the K5 mZn construct,
which lacks a functional RING-CH domain, is also unable to
modulate increased RTK endocytosis. Together, this data can be
interpreted to mean that ubiquitylation is likely playing a role in
the alteration of RTK signaling by K5. We are currently
engineering a series of THP-1 cell lines to express HA-tagged
ubiquitin to explore this possibility.
Numerous studies have documented a role for KSHV infection
in regulating cytokine production by monocytes and macrophages
[14-17,63,64]. In toto, these published studies suggest a mechanism
whereby KSHV infection of monocytes, as well as endothelial
cells, drives the production of pro-inflamatory cytokines promoting
KS tumor outgrowth [65,66]. Our data extend this hypothetical
model further in two ways. First, our findings demonstrate that K5
can alter the responsiveness of expressing cells to growth factors,
allowing for responsiveness to very low levels of these pro-growth
mediators. Second our data provides additional evidence for the
possibility that viral infection and K5 expression, in particular,
could be driving changes in the tumor microenvironment.
Published work from Delgado et al. has demonstrated, for example,
that at early time points post-infection KSHV drives increased
lactate production in TIME cells [35]. Stable K5 expression in
TIME cells similarly led to increased lactate production, as well as
alterations in PKM2 phosphorylation, opening the possibility that
the increases in lactate production seen during infection are due to
the early production of K5 protein (Fig. 2A, C & E). Lending
weight to this possibility is the fact that we did not observe
increased lactate production in KSHV-infected TIME cells when
we looked at time points ranging from 4-8 weeks post-infection
when K5 protein expression is low (data not shown). We are
actively working to produce and characterize a K5 gene deleted
virus to further pursue this question.
Overall, in this report we provide evidence that the KSHV K5
protein is able to drive alterations in cellular signaling cascades,
potentially contributing to KSHV oncogenesis. We believe that
this is the first report of a virally-encoded E3 ubiquitin ligase
contributing to changes in cellular metabolism and proliferation
through a direct alteration of RTK endocytosis rates and signaling
output. These data open a new line of inquiry the mechanisms of
KSHV oncogenesis and the biology of both K5 and its cellular
homologues.
Methods
Cell culture, transfection and growth curves
THP-1 and 293T cells were grown in RPMI plus 10% Fetal
Bovine Serum (FBS) and Dulbecco’s modified Eagle’s medium plus
10% FBS, respectively. TIME cells were grown in EBM medium
with complete bullet kit (Lonza, Walkersville, MD). Stable cell lines
were established by retroviral transduction, as described previously
[32]. THP-1 cells were selected with 1 mg of G418 per ml for 2
weeks following transduction and then characterized for construct
expression by radioactive IP. The 293T cell line was transfected
using Transfectin (Bio-Rad) according to the manufacturer’s
recommendations. To determine growth rates, cells were seeded,
unless otherwise indicated, at 1x10
5/ml in RPMI supplemented
with the indicated amount of FBS. Viable cell numbers were
determined using Trypan Blue staining and counting by hemato-
cytometer. For growth curves with sunitinib, either DMSO
(Mallinckrodt Baker) or 0.75mM sunitinib (Sigma-Aldrich) was
added to cultures and replenished daily.
Plasmid constructs
All pEF-K5 WT and mutant constructs used in this paper were
generated using oligonucleotide-directed mutagenesis described
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pLXSN (gift of Dr. D. DiMaio) for retroviral transduction or
pcDEF-GST-AU1 (gift of Dr. J. Jung) for pulldown experiments
and sequence verified. The Flt4, EGFR and PDGFR-ß expression
constructs were the gifts of Drs J. Groopman, J. Jung and D.
DiMaio, respectively.
Antibodies
Antibodies for flow cytometry. From Santa Cruz
Biotechnology: anti-Flt-3/Flk-2 (SF1.340), anti-Flt-4 (C-20), anti-
PDGFR-ß (958); From Dako: MHC class I (clone W6/32); From
Becton-Dickinson: fluorescein isothiocyanate-, PE-, or allophy-
cocyanin-conjugatedisotype controls (Simultest), all secondaries.
Antibodies for IP. From Santa Cruz Biotechnology: anti-Flt-
3 (SF1.340), anti-Flt-4 (C20), anti-PDGFR-ß (958); From
Millipore: anti-EGFR (rabbit monoclonal).
Antibodies for WB. From Santa Cruz Biotechnology: anti-
HIF-1a (H-206), anti-p-Akt1/2/3(Ser 473)-R, anti-Akt1/2 (N-19),
anti-p-thr (BDI141), anti-Flt-3/Flk-2 (SF1.340), anti-Flt-4 (C-20),
anti-PDGFR-ß (958), anti-a-actinin (C-20), anti-Erk2 (D-2) or
anti-GST (B-14); From Millipore: anti-phosphotyrosine (4G10
Platinum), anti-EGFR (04-338), anti-p-Akt1 (Thr 308); From
Abcam: anti-phosphoserine (ab9332-100); From Cell Signalling
Technology: anti-phospho-p44/42 MAPK (Erk1/2) (Thr202/
Tyr204) (D13.14.4E).
Cell cycle and apoptosis assays
THP-1 cells lines were seeded in triplicates, 5 x 10
5 per sample,
in the indicated amount of serum. Five days post seeding they were
stained for 15 minutes using Annexin-V-FLOUS staining kit
(Roche), according to the manufacturer’s recommendations and
analyzed by flow cytometry. Cell cycle analysis was performed by
standard propidium iodide (Sigma) staining protocol followed by
flow cytometry and analysis with FlowJo software (Tree Star).
Measurement of lactate production, glucose uptake and
mitochondrial function
To measure lactate production, cells were seeded at 1x10
5 cells/
ml and were enumerated and supernatant was taken at the
indicated time points. Lactate concentration in the supernatants
was measured by colorometric assay (Biovision) according to the
manufacturer’s recommendations. For glucose uptake assay, 5x10
5
cells per sample were washed and starved in PBS for 15 minutes
then incubated with 0.05mM 2-NBDG (Invitrogen) plus 5mM
Glucose-D (Mallinckrodt Baker) in PBS for a period of 30 minutes,
followed by flow cytometric analysis. Mitochondrial function was
determined by staining with Mitotracker Green and Mitotracker
Red (Invitrogen) for 30 minutes, according to the manufacturer’s
recommendations.
Receptor levels and endocytosis
Cells at 5x10
5 per sample were fixed with 3% paraformalde-
hyde and incubated with indicated antibodies for 45 minutes in
either flow buffer (0.5% FBS-PBS) or 0.2mM Saponin buffer for
surface or total levels of RTKs, respectively. RTK internalization
kinetics was determined by incubating cells, 6x10
6 cells/sample,
with DMSO (mock) or 80mM Dynasore (EMD Chemicals) for 1hr
at 37uC. Cells were then washed and incubated at 37uC for the
indicated time periods. At the indicated times, 0.5 x 10
6 cells were
transferred to ice and sodium azide was added to a final
concentration of 0.05% to stop endocytosis. Following collection
of all time points, cells were then fixed and stained with the
indicated RTK antibodies.
Immunoprecipitation, GST pulldown and immunoblot
assays
Proteins were extracted from cells, normalized by BCA assay
(Pierce) and subjected to adsorption with protein A-agarose
(SCBT) plus antibody for IP, incubation with glutathione-
sepharose agarose (Amersham) for pulldown, or directly subjected
to SDS-polyacrylamide gel electrophoresis and WB, as previously
described [31]. The membranes were incubated with appropriate
secondary antibody conjugated with horseradish peroxidase
(SCBT) and were visualized using the enhanced chemilumines-
cence system (Roche Diagnostics) and a LAS 3000 camera
(FujiFilm).
Human Phospho-RTK arrays
To examine receptor activation, THP-1 cells were serum
starved overnight and stimulated with 10% FBS and pervanadate
for 10 minutes. Normalized WCL from cells were incubated with a
Human Phospho-RTK Array (R& D systems) and developed
according to the manufacturer’s recommendations.
RT-Profiler PCR Array
RNA was extracted from 1*10
6 vector- or K5-expressing THP-
1 cell lines, grown in RPMI + 10% FBS, using the RNeasy Mini
Kit (Qiagen). The Human Hypoxia Signaling Pathway RT-
Profiler PCR Array (SABiosciences) was performed according to
the manufacturer’s protocols.
Ligand-stimulation assay
For ligand stimulation studies, THP-1 cells were serum starved
overnight and stimulated with 40ng/ml Flt-3/Flk-2 ligand
(Calbiochem) or 20ng/ml PDGF-ß (Millipore) for ten minutes.
After ligand washing, the cells were resuspended in serum free
RPMI media and aliquot of cells were collected at the indicated
time points and subjected to WB, as described above.
Supporting Information
Figure S1 K5-expressing THP-1 are insensitive to charcoal
depletion of serum factors and display greater glutamine
dependancy.
Found at: doi:10.1371/journal.ppat.1001331.s001 (0.32 MB EPS)
Figure S2 K5-expressing THP-1 cells display altered receptor
tyrosine kinase activation.
Found at: doi:10.1371/journal.ppat.1001331.s002 (0.43 MB EPS)
Figure S3 Growth of K5-expressing THP-1 cells is sensitive to
rapamycin.
Found at: doi:10.1371/journal.ppat.1001331.s003 (0.21 MB EPS)
Table S1 qRT results of hypoxia-related genes altered in KSHV
K5-expressing monocytes.
Found at: doi:10.1371/journal.ppat.1001331.s004 (2.87 MB EPS)
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